☆ 4.6 Article

Hepatitis C treatment and long-term outcome of patients with hepatocellular carcinoma after resection

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrence

Hou-Ying Cheng et al.

Summary: This study investigated the changes in transplantability between primary and recurrent Hepato-cellular carcinoma (HCC) after hepatic resection (HR) and identified risk factors for nontransplantable recurrence (NTR). The study found that tumor diameter, resection extent, pathological grade, microvascular invasion, and early recurrence were associated with NTR. The overall transplantable pool increased after HR, suggesting that liver transplantation may not be necessary for some patients.

HPB (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Towards a new definition of decompensated cirrhosis

Gennaro D'Amico et al.

Summary: There is a consensus that clinical complications indicate the transition from compensated to decompensated cirrhosis. Decompensation significantly worsens patient prognosis and is a key factor in predicting mortality. Decompensated cirrhosis can follow two distinct pathways: acute and non-acute, with acute decompensation often representing further deterioration.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antivirals

Tsuyoshi Fukumoto et al.

Summary: This study aimed to evaluate the prognosis of hepatitis C-related hepatocellular carcinoma (C-HCC) in the era of direct-acting antivirals (DAAs). The results showed a significant improvement in the prognosis of C-HCC with the advent of DAAs, while the prognosis of nonviral HCC did not improve significantly.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Article Medicine, General & Internal

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma

Yu-Syuan Chen et al.

Summary: This study found that DAA treatment could reduce the risk of recurrence in patients with early stage HCV-related HCC. Liver cirrhosis, microvascular invasion, and high AFP levels were identified as independent factors for HCC recurrence.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

Hironori Ochi et al.

Summary: DAAs treatment after HCC can prevent hepatic functional reserve deterioration and significantly improve both recurrence and survival rates. This study showed that in patients receiving DAAs treatment, the 48-month survival rate was 91.0% and the recurrence rate was 36.7%, both significantly better than in patients not receiving DAAs treatment.

JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis

Cheng-Maw Ho et al.

Summary: This study analyzed the survival of patients with post-transplant HCC recurrence, finding that early recurrence within two years after surgery had a poorer prognosis compared to late recurrence. Factors such as transplant era before 2008 and radiofrequency ablation were associated with better outcomes, while receiving sorafenib and radiotherapy were linked to poorer prognosis.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside

Don C. Rockey et al.

Summary: The introduction of novel and highly effective direct-acting antiviral drugs has revolutionized the treatment of HCV by curing a broad range of patients, including those with established advanced fibrosis, cirrhosis, comorbidities, and complications. Fibrosis is a dynamic process involving both extracellular matrix deposition and degradation.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis

Leonardo Frazzoni et al.

Summary: Research shows that approximately 30% of patients with a history of HCC will experience HCC recurrence after receiving DAA treatment, with the risk of recurrence higher soon after treatment ends. Studies from Europe, the United States, Egypt, and Asia show variations in recurrence rates, but overall, DAA treatment seems to lower the risk of HCC recurrence compared to IFN and no intervention.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Immunology

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data

Chun-Ming Hong et al.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatic benefits of HCV cure

Vincenza Calvaruso et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population

Ming-Lung Yu et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Oncology

Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct-acting antivirals

Shogo Tanaka et al.

JOURNAL OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL recommendations on treatment of hepatitis C: Final update of the series

Jean-Michel Pawlotsky et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Primary Health Care

Variable selection strategies and its importance in clinical prediction modelling

Mohammad Ziaul Islam Chowdhury et al.

FAMILY MEDICINE AND COMMUNITY HEALTH (2020)

添加到收藏夹

Article Oncology

Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma

Derek J. Erstad et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Giuseppe Cabibbo et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Infectious Diseases

Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection

Arpan Mohanty et al.

CURRENT HIV/AIDS REPORTS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?

George N. Ioannou et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Amit G. Singal et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy

Mizuki Nishibatake Kinoshita et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

Antonietta Romano et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Managing hepatitis C in patients with the complications of cirrhosis

Marcus M. Muecke et al.

LIVER INTERNATIONAL (2018)

添加到收藏夹

Article Oncology

Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status

Masaki Koda et al.

LIVER CANCER (2018)

添加到收藏夹

Editorial Material Medicine, General & Internal

Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies

Grace Hui-Min Wu et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis

Silvia Martini et al.

LIVER INTERNATIONAL (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

Reem Waziry et al.

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Article

Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma

Young Mi Hong et al.

TUMOR BIOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Hepatitis C virus infection

Michael P. Manns et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents

George Cholankeril et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

APASL consensus statements and recommendation on treatment of hepatitis C

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2016)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Direct acting antivirals for decompensated cirrhosis. Efficacy and safety are now established

Michael P. Curry

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Reversion of disease manifestations after HCV eradication

Adriaan J. van der Meer et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

Maria Reig et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Editorial Material Medicine, General & Internal

Hepatitis C virus infection in Taiwan: Past, present, and future

Jia-Horng Kao

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)

添加到收藏夹

Article Surgery

Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis

Parissa Tabrizian et al.

ANNALS OF SURGERY (2015)

添加到收藏夹

Article Oncology

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade

Philip J. Johnson et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection

Yao-Chun Hsu et al.

GUT (2015)

添加到收藏夹

Review Medicine, General & Internal

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies

Rebecca L. Morgan et al.

ANNALS OF INTERNAL MEDICINE (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Richard Moreau et al.

GASTROENTEROLOGY (2013)

添加到收藏夹

Article Oncology

Long-Term Outcomes After Resection Versus Transplantation for Hepatocellular Carcinoma Within UCSF Criteria

Cheng-Maw Ho et al.

ANNALS OF SURGICAL ONCOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Adriaan J. van der Meer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer

D. R. McGivern et al.

ONCOGENE (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Timing of Hepatitis C Antiviral Therapy in Patients with Advanced Liver Disease: A Decision Analysis Model

Sammy Saab et al.

LIVER TRANSPLANTATION (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Pegylated interferon α-2a versus standard interferon α-2a for treatment-naive dialysis patients with chronic hepatitis C:: a randomised study

C-H Liu et al.

GUT (2008)

添加到收藏夹

Article Oncology

What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis

M Takata et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.